Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type
- 24 July 2009
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1281, 117-127
- https://doi.org/10.1016/j.brainres.2009.04.010
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Cognitive profiles in dementiaNeurology, 2008
- Selenium effectively inhibits ROS-mediated apoptotic neural precursor cell death in vitro and in vivo in traumatic brain injuryBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Selenium Level and Cognitive Function in Rural Elderly ChineseAmerican Journal of Epidemiology, 2007
- Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in ratsBehavioural Brain Research, 2006
- Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathwayJournal of Neurochemistry, 2006
- Selenium reduces the proapoptotic signaling associated to NF-κB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatumSynapse, 2005
- Selenium and brain function: a poorly recognized liaisonBrain Research Reviews, 2004
- Role of Free Radicals in the Neurodegenerative DiseasesDrugs & Aging, 2001
- Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortexNeuroscience Letters, 1991
- The role of guanosine 5′-triphosphate in polypeptide chain elongationBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1978